Improvement of Implant Placement after Bone Augmentation of Severely Resorbed Maxillary Sinuses with 'Tent-Pole' Grafting Technique in Combination with rhBMP-2

Chin J Dent Res. 2017;20(1):9-17. doi: 10.3290/j.cjdr.a37737.


Objective: To study the clinical effect of short implant placement using osteotome sinus floor elevation technique and tent-pole grafting technique with recombinant human bone morphogenetic protein 2 (rhBMP-2) in severely resorbed maxillary area.

Methods: Eleven patients with insufficient bone height in the posterior maxillary area were included. According to the native bone height and crown height space (CHS), the patients were divided into two groups: immediate placement of short implants with simultaneous bone augmentation (group A, 5 patients) and delayed dental implant placement (4 to 6 months) after bone augmentation. The rhBMP-2 was added into a deproteinised bovine bone mineral (DBBM) bone grafting material to shorten the treatment procedure and enhance the final effect of bone augmentation in both groups. Tent-pole grafting technique was applied for vertical bone augmentation in group B (6 patients).

Results: The success rate of the implants placed was 100% in both groups. In group A, the short implants treatment was successful, with a vertical gain of 1.5 to 6.4 mm in bone height after 4 to 6 months. In group B, the tent-pole grafting procedure in combination with DBBM and rhBMP-2 increased vertical bone height between 3.1 and 8.1 mm, an optimistic and adequate increase for implant placement. This bone increase was maintained following implant placement and final crown placement in the maxillary region (3.5 to 7.3 mm).

Conclusion: The tent-pole grafting technique was a viable alternative choice to lateral sinus floor elevation in cases with excessive CHS. The application of rhBMP-2 with a shortened treatment time demonstrated positive outcomes in sinus floor augmentation procedures.

MeSH terms

  • Adult
  • Aged
  • Bone Morphogenetic Protein 2 / therapeutic use*
  • Bone Resorption
  • Bone Transplantation / methods*
  • Dental Implantation, Endosseous
  • Dental Implants
  • Dental Restoration Failure
  • Female
  • Humans
  • Jaw, Edentulous / surgery
  • Male
  • Maxillary Sinus / surgery*
  • Middle Aged
  • Recombinant Proteins / therapeutic use
  • Sinus Floor Augmentation / methods*
  • Transforming Growth Factor beta / therapeutic use*
  • Young Adult


  • Bone Morphogenetic Protein 2
  • Dental Implants
  • Recombinant Proteins
  • Transforming Growth Factor beta
  • recombinant human bone morphogenetic protein-2